RPE barrier breakdown in diabetic retinopathy: Seeing is believing

Journal of Ocular Biology, Diseases, and Informatics

Volumn 4, Issue 1-2, 2011, Pages 83-92

  Xu, Hui Zhuo ^a,c   Song, Zhiming ^a   Fu, Shuhua ^a   Zhu, Meili ^a   Le, Yun Zheng ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Barrier; Diabetic retinopathy; Fluorescent microscopy; Leakage; Macular edema; RPE

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CADHERIN; DOCOSAHEXAENOIC ACID; FENOFIBRATE; FIBRINOGEN; GELATINASE B; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 6; JANUS KINASE 2; MESSENGER RNA; OCCLUDIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLACENTAL GROWTH FACTOR; PROTEIN ZO1; PROTEIN ZO2; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ARTICLE; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; ENDOPLASMIC RETICULUM; FATTY ACID TRANSPORT; FLUORESCENCE MICROSCOPY; HUMAN; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MEMBRANE PERMEABILITY; MOLECULAR DYNAMICS; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; OXIDATIVE STRESS; PATHOGENESIS; PHAGOCYTOSIS; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINOPATHY; SIGNAL TRANSDUCTION; UPREGULATION;

RODENTIA;

EID: 84863982016     PISSN: 19368437     EISSN: 19368445     Source Type: Journal    
DOI: 10.1007/s12177-011-9068-4     Document Type: Article

References (88)

1. Bill A. Blood circulation and fluid dynamics in the eye. Physiol Rev. 1975;55:383-417.
2. Young RW, Bok D. Participation of the retinal pigment epithelium in the rod outer segment renewal process. J Cell Biol. 1969;42:392-403.
3. Benolken RM, Anderson RE, Wheeler TG. Membrane fatty acids associated with the electrical response in visual excitation. Science. 1973;182:1253-4.
4. Gordon WC, Rodriguez de Turco EB, Bazan NG. Retinal pigment epithelial cells play a central role in the conservation of docosahexaenoic acid by photoreceptor cells after shedding and phagocytosis. Curr Eye Res. 1992;11:73-83.
5. Philp NJ, Ochrietor JD, Rudoy C, Muramatsu T, Linser PJ. Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse. Invest Ophthalmol Vis Sci. 2003;44:1305-11. (Pubitemid 36297854)
6. Kumagai AK, Glasgow BJ, Pardridge WM. GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. Invest Ophthalmol Vis Sci. 1994;35:2887-94. (Pubitemid 24149803)
7. Saari JC. Biochemistry of visual pigment regeneration: the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2000;41:337-48. (Pubitemid 30080432)
8. Bialek S, Miller SS. K+ and Cl- transport mechanisms in bovine pigment epithelium that could modulate subretinal space volume and composition. J Physiol. 1994;475:401-17.
9. Hamann S. Molecular mechanisms of water transport in the eye. Int Rev Cytol. 2002;215:395-431. (Pubitemid 34280301)
10. Simo R, Villarroel M, Corraliza L, Hernandez C, Garcia-Ramirez M. The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier-implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol. 2010;2010:190724.
11. Rizzolo LJ, Peng S, Luo Y, XiaoW. Integration of tight junctions and claudins with the barrier functions of the retinal pigment epithelium. Prog Retin Eye Res. 2011;30:296-323.
12. Runkle EA, Antonetti DA. The blood-retinal barrier: structure and functional significance. Meth Mol Biol. 2011;686:133-48.
13. Konari K, Sawada N, Zhong Y, Isomura H, Nakagawa T, Mori M. Development of the blood-retinal barrier in vitro: formation of tight junctions as revealed by occludin and ZO-1 correlates with the barrier function of chick retinal pigment epithelial cells. Exp Eye Res. 1995;61:99-108.
14. Rizzolo LJ. Polarity and the development of the outer blood-retinal barrier. Histol Histopathol. 1997;12:1057-67. (Pubitemid 27410463)
15. Kojima S, Rahner C, Peng S, Rizzolo LJ. Claudin 5 is transiently expressed during the development of the retinal pigment epithelium. J Membr Biol. 2002;186:81-8. (Pubitemid 34252644)
16. Luo Y, Fukuhara M, Weitzman M, Rizzolo LJ. Expression of JAMA, AF-6, PAR-3 and PAR-6 during the assembly and remodeling of RPE tight junctions. Brain Res. 2006;1110:55-63. (Pubitemid 44344603)
17. Daniele LL, Adams RH, Durante DE, Pugh Jr EN, Philp NJ. Novel distribution of junctional adhesion molecule-C in the neural retina and retinal pigment epithelium. J Comp Neurol. 2007;505:166-76. (Pubitemid 350013040)
18. Economopoulou M, Hammer J, Wang F, Fariss R, Maminishkis A, Miller SS. Expression, localization, and function of junctional adhesion molecule-C (JAM-C) in human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2009;50:1454-63.
19. Koh SW. The chick retinal pigment epithelium grown on permeable support demonstrates functional polarity. Exp Cell Res. 1989; 181:331-47.
20. Shukla SY, Singh YK, Shukla D. Role of nectin-1, HVEM, and PILR-alpha in HSV-2 entry into human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2009;50:2878-87.
21. Tiwari V, Oh MJ, Kovacs M, Shukla SY, Valyi-Nagy T, Shukla D. Role for nectin-1 in herpes simplex virus 1 entry and spread in human retinal pigment epithelial cells. FEBS J. 2008;275:5272-85.
22. Marrs JA, Andersson-Fisone C, JeongMC, Cohen-Gould L, Zurzolo C, Nabi IR, Rodriguez-Boulan E, Nelson WJ. Plasticity in epithelial cell phenotype: modulation by expression of different cadherin cell adhesion molecules. J Cell Biol. 1995;129:507-19.
23. Vinores SA, Gadegbeku C, Campochiaro PA, Green WR. Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol. 1989;134:231-5. (Pubitemid 19063877)
24. Weinberger D, Fink-Cohen S, Gaton DD, Priel E, Yassur Y. Nonretinovascular leakage in diabetic maculopathy. Br J Ophthalmol. 1995;79:728-31.
25. Soliman W, Sander B, Jorgensen TM. Enhanced optical coherence patterns of diabetic macular oedema and their correlation with the pathophysiology. Acta Ophthalmol Scand. 2007;85:613-7. (Pubitemid 47316759)
26. Gaucher D, Sebah C, Erginay A, Haouchine B, Tadayoni R, Gaudric A, Massin P. Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema. Am J Ophthalmol. 2008;145:289-96.
27. Voo I, Mavrofrides EC, Puliafito CA. Clinical applications of optical coherence tomography for the diagnosis and management ofmacular diseases. Ophthalmol Clin North Am. 2004;17:21-31. (Pubitemid 38507699)
28. Ozdemir H, Karacorlu M, Karacorlu S. Serous macular detachment in diabetic cystoid macular oedema. Acta Ophthalmol Scand. 2005;83:63-6. (Pubitemid 40326423)
29. Marmor MF. Mechanisms of fluid accumulation in retinal edema. Doc Ophthalmol. 1999;97:239-49.
30. Vinores SA, Derevjanik NL, Ozaki H, Okamoto N, Campochiaro PA. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol. 1999;97:217-28.
31. Wang J, Xu X, Elliott MH, Zhu M, Le Y. Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes. 2010;59:2297-3005.
32. Xu HZ, Le YZ. Significance of outer blood-retina barrier breakdown in diabetes and ischemia. Invest Ophthalmol Vis Sci. 2011;52:2160-4.
33. Aizu Y, Oyanagi K, Hu J, Nakagawa H. Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin- diabetic rats. Neuropathology. 2002;22:161-70. (Pubitemid 35252706)
34. Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA. Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium. Histochem J. 1993;25:648-63. (Pubitemid 23288882)
35. Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition. Exp Eye Res. 1993;57:723-35. (Pubitemid 24039476)
36. Kirber WM, Nichols CW, Grimes PA, Winegrad AI, Laties AM. A permeability defect of the retinal pigment epithelium. Occurrence in early streptozocin diabetes. Arch Ophthalmol. 1980;98:725-8. (Pubitemid 10110355)
37. Pautler EL, Ennis SR. The effect of induced diabetes on the electroretinogram components of the pigmented rat. Invest Ophthalmol Vis Sci. 1980;19:702-5. (Pubitemid 11042057)
38. MacGregor LC, Matschinsky FM. Experimental diabetes mellitus impairs the function of the retinal pigmented epithelium. Metabolism. 1986;35:28-34. (Pubitemid 16104320)
39. Rimmer T, Linsenmeier RA. Resistance of diabetic rat electroretinogram to hypoxemia. Invest Ophthalmol Vis Sci. 1993;34:3246-52. (Pubitemid 23346656)
40. Decanini A, Karunadharma PR, Nordgaard CL, Feng X, Olsen TW, Ferrington DA. Human retinal pigment epithelium proteome changes in early diabetes. Diabetologia. 2008;51:1051-61.
41. Bai Y, Ma JX, Guo J, Wang J, Zhu M, Chen Y, Le YZ. Muller cellderived VEGF is a significant contributor to retinal neovascularization. J Pathol. 2009;219:446-54.
42. Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl. 2000;77:S113-9.
43. Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest. 1996;74:819-25. (Pubitemid 26117141)
44. Hammes HP, Lin J, Bretzel RG, BrownleeM, Breier G. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes. 1998;47:401-6. (Pubitemid 28104202)
45. Mousa SA, Lorelli W, Campochiaro PA. Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells. J Cell Biochem. 1999;74:135-43. (Pubitemid 29270036)
46. Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology. 2003;110:1690-6. (Pubitemid 37025424)
47. Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD, et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci. 2001;42:2408-13. (Pubitemid 32848873)
48. Korte GE, Cushin S, Delman N. Permeability of regenerating and atrophic choriocapillaris in the rabbit. Acta Anat (Basel). 1989; 134:144-50. (Pubitemid 19102703)
49. Ghassemifar R, Lai CM, Rakoczy PE. VEGF differentially regulates transcription and translation of ZO-1alpha+ and ZO-1alpha-and mediates trans-epithelial resistance in cultured endothelial and epithelial cells. Cell Tissue Res. 2006;323:117-25. (Pubitemid 41677690)
50. Kannan R, Zhang N, Sreekumar PG, Spee CK, Rodriguez A, Barron E, Hinton DR. Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells. Mol Vis. 2006;12:1649-59. (Pubitemid 46050311)
51. Hartnett ME, Lappas A, Darland D, McColm JR, Lovejoy S, D'Amore PA. Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism. Exp Eye Res. 2003;77:593-9. (Pubitemid 37188734)
52. Ablonczy Z, Crosson CE. VEGF modulation of retinal pigment epithelium resistance. Exp Eye Res. 2007;85:762-71. (Pubitemid 350166363)
53. Miyamoto N, de Kozak Y, Jeanny JC, Glotin A, Mascarelli F, Massin P, BenEzra D, Behar-Cohen F. Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy. Diabetologia. 2007;50:461-70.
54. Cai J, Wu L, Qi X, Shaw L, Li Calzi S, Caballero S, Jiang WG, Vinores SA, Antonetti D, Ahmed A, et al. Placenta growth factor-1 exerts time-dependent stabilization of adherens junctions following VEGF-induced vascular permeability. PLoS One. 2011;6:e18076.
55. Ablonczy Z, Prakasam A, Fant J, Fauq A, Crosson C, Sambamurti K. Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gamma-secretase. J Biol Chem. 2009;284:30177-86.
56. Peng S, Adelman RA, Rizzolo LJ. Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions. Invest Ophthalmol Vis Sci. 2010;51:3216-25.
57. Villarroel M, Garcia-Ramirez M, Corraliza L, Hernandez C, Simo R. Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cells. Exp Eye Res. 2009;89:913-20.
58. Ablonczy Z, Dahrouj M, Tang PH, Liu Y, Sambamurti K, Marmorstein AD, Crosson CE. Human retinal pigment epithelium cells as functional models for the RPE in vivo. Invest Ophthalmol Vis Sci. 2011;52(12):8614-20.
59. Villarroel M, Garcia-Ramirez M, Corraliza L, Hernandez C, Simo R. High glucose concentration leads to differential expression of tight junction proteins in human retinal pigment epithelial cells. Endocrinol Nutr. 2009;56:53-8.
60. Bailey TA, Kanuga N, Romero IA, Greenwood J, Luthert PJ, Cheetham ME. Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2004; 45:675-84. (Pubitemid 38140530)
61. Chang C, Wang X, Caldwell RB. Serum opens tight junctions and reduces ZO-1 protein in retinal epithelial cells. J Neurochem. 1997;69:859-67. (Pubitemid 27327991)
62. Chang CW, Ye L, Defoe DM, Caldwell RB. Serum inhibits tight junction formation in cultured pigment epithelial cells. Invest Ophthalmol Vis Sci. 1997;38:1082-93. (Pubitemid 27227038)
63. Garcia-Ramirez M, Hernandez C, Ruiz-Meana M, Villarroel M, Corraliza L, Garcia-Dorado D, Simo R. Erythropoietin protects retinal pigment epithelial cells against the increase of permeability induced by diabetic conditions: essential role of JAK2/PI3K signaling. Cell Signal. 2011;23:1596-602.
64. Chen Y, Yang P, Li F, Kijlstra A. The effects of Th17 cytokines on the inflammatory mediator production and barrier function of ARPE-19 cells. PLoS One. 2011;6:e18139.
65. Abe T, Sugano E, Saigo Y, Tamai M. Interleukin-1beta and barrier function of retinal pigment epithelial cells (ARPE-19): aberrant expression of junctional complex molecules. Invest Ophthalmol Vis Sci. 2003;44:4097-104. (Pubitemid 37047987)
66. Zhou J, He S, Zhang N, Spee C, Zhou P, Ryan SJ, Kannan R, Hinton DR. Neutrophils compromise retinal pigment epithelial barrier integrity. J Biomed Biotechnol. 2010;2010:289360.
67. Hiukka A, Leinonen E, Jauhiainen M, Sundvall J, Ehnholm C, Keech AC, Taskinen MR. Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus. Diabetologia. 2007;50:2067-75. (Pubitemid 47373844)
68. Trudeau K, Roy S, GuoW, Hernandez C, Villarroel M, Simo R, Roy S. Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability. Invest Ophthalmol Vis Sci. 2011;52:6348-54.
69. Villarroel M, Garcia-Ramirez M, Corraliza L, Hernandez C, Simo R. Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1beta by suppressing AMP-activated protein kinase (AMPK) activation. Diabetologia. 2011;54:1543-53.
70. Miranda S, Gonzalez-Rodriguez A, Garcia-Ramirez M, Revuelta-Cervantes J, Hernandez C, Simo R, Valverde AM. Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions. J Cell Physiol. 2011. doi:10.1002/jcp.22970.
71. Tso MO, Cunha-Vaz JG, Shih CY, Jones CW. Clinicopathologic study of blood-retinal barrier in experimental diabetes mellitus. Arch Ophthalmol. 1980;98:2032-40. (Pubitemid 11250662)
72. Gregor Z, Ryan SJ. Blood-retinal barrier after blunt trauma to the eye. Graefe's Arch Clinical Exp Ophthalmol. 1982;219:205-8. (Pubitemid 13247323)
73. Korte GE, Bellhorn RW, Burns MS. Ultrastructure of blood-retinal barrier permeability in rat phototoxic retinopathy. Invest Ophthalmol Vis Sci. 1983;24:962-71. (Pubitemid 13036949)
74. Uyama M, Matsunaga H, Matsubara T, Fukushima I, Takahashi K, Nishimura T. Indocyanine green angiography and pathophysiology of multifocal posterior pigment epitheliopathy. Retina. 1999;19:12-21. (Pubitemid 30387535)
75. Yoshioka H, Katsume Y, Ishibashi R. Experimental central serous chorioretinopathy. II: further clinical findings. Kurume Med J. 1981;28:189-96. (Pubitemid 12040482)
76. Soliman W, Sander B, Hasler PW, Larsen M. Correlation between intraretinal changes in diabetic macular oedema seen in fluorescein angiography and optical coherence tomography. Acta Ophthalmol. 2008;86:34-9. (Pubitemid 351512467)
77. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35:101-11. (Pubitemid 24046832)
78. Do carmo A, Ramos P, Reis A, Proenca R, Cunha-vaz JG. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes. Exp Eye Res. 1998;67:569-75. (Pubitemid 29005154)
79. Googe JM, Hirose T, Apple DJ, Melgen S. Vitreous hemorrhage secondary to age-related macular degeneration. Surv Ophthalmol. 1987;32:123-30. (Pubitemid 18004776)
80. el Baba F, Jarrett 2nd WH, Harbin Jr TS, Fine SL, Michels RG, Schachat AP, Green WR. Massive hemorrhage complicating agerelated macular degeneration. Clinicopathologic correlation and role of anticoagulants. Ophthalmology. 1986;93:1581-92. (Pubitemid 17216936)
81. Takeuchi A, Kricorian G, Marmor MF. Albumin movement out of the subretinal space after experimental retinal detachment. Invest Ophthalmol Vis Sci. 1995;36:1298-305.
82. Aizu Y, Katayama H, Takahama S, Hu J, Nakagawa H, Oyanagi K. Topical instillation of ciliary neurotrophic factor inhibits retinal degeneration in streptozotocin-induced diabetic rats. Neuroreport. 2003;14:2067-71.
83. Negi A, Marmor MF. Experimental serous retinal detachment and focal pigment epithelial damage. Arch Ophthalmol. 1984; 102:445-9. (Pubitemid 14197300)
84. Nicholson BP, Schachat AP. A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefe's Arch Clin Exp Ophthalmol. 2011;248:915-30.
85. Le YZ. Conditional gene targeting: dissecting the cellular mechanisms of retinal degenerations. J Ophthalmol. 2011;2011:806783.
86. Le YZ, Zheng W, Rao PC, Zheng L, Anderson RE, Esumi N, Zack DJ, Zhu M. Inducible expression of cre recombinase in the retinal pigmented epithelium. Invest Ophthalmol Vis Sci. 2008;49:1248-53.
87. Le YZ, Bai Y, Zhu M, Zheng L. Temporal requirement of RPEderived VEGF in the development of choroidal vasculature. J Neurochem. 2010;112:1584-92.
88. Iacovelli J, Zhao C, Wolkow N, Veldman P, Gollomp K, Ojha P, Lukinova N, King A, Feiner L, Esumi N, et al. Generation of Cre transgenic mice with postnatal RPE-specific ocular expression. Invest Ophthalmol Vis Sci. 2011;52:1378-83.